Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review

Publisher： Karger

E-ISSN： 1660-3818|42|5|294-301

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.42, Iss.5, 2015-08, pp. : 294-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thymoma with Autoimmune Hemolytic Anemia

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-11 ,pp. : 764-768

Karger

Access to resources Recommend Favorite

Results of Treatment with Rituximab (Anti-CD20) in Three Patients with Autoimmune Hemolytic Anemia and/or Immune Thrombocytopenia and a Concise Review of Reported Cases

By  

Transfusion Medicine and Hemotherapy, Vol. 29, Iss. 5, 2002-10 ,pp. : 277-281

Karger

Access to resources Recommend Favorite

Role of Complement in Autoimmune Hemolytic Anemia

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 5, 2015-09 ,pp. : 303-310

Karger

Access to resources Recommend Favorite

The Clinical Pictures of Autoimmune Hemolytic Anemia

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 5, 2015-09 ,pp. : 317-324

Karger

Access to resources Recommend Favorite

New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 5, 2015-09 ,pp. : 287-293

Karger

Access to resources Recommend Favorite